Preoperative and postoperative response to inhaled nitric oxide

Scandinavian Cardiovascular Journal

Volumn 34, Issue 1, 2000, Pages 46-52

  Turanlahti, Maila I ^b   Laitinen, Pirjo O ^c   Pesonen, Erkki J ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NONE

Author keywords

Congenital heart disease; Nitric oxide; Postoperative; Pulmonary hypertension

Indexed keywords

ADRENALIN; ALFENTANIL; AMRINONE; DOBUTAMINE; FENTANYL; MIDAZOLAM; NITRIC OXIDE; OXYGEN; PANCURONIUM BROMIDE;

ARTICLE; CALORIMETER; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; FEMALE; HEART SURGERY; HEMODYNAMICS; HUMAN; INFANT; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; OXIMETRY; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SIDE EFFECT; VASODILATATION;

EID: 0034034714     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430050142396     Document Type: Article

References (36)

1. Hopkins RA, Bull C, Haworth SG, de Levai MR, Stark J. Pulmonary hypertensive crisis following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg 1991; 5: 628-634.
2. Celermajer DS, Cullen S, Deanfield JE. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary haemodynamics. Circulation 1993; 87: 440-446.
3. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993; 88: 2128-2138.
4. Turanlahti MI, Laitinen PO, Sarna SJ, Pesonen EJ. Nitric oxide, oxygen, and prostacyclin in children with pulmonary hypertension. Heart 1998; 79: 169-174.
5. Weyland W, Weyland A, Fritz U, Redecker K, Ensink F-B, Braun U. A new paediatric metabolic monitor. Intensive Care Med 1994; 20: 51-57.
6. Takala J, Keinänen O, Väisänen P, Kari A. Measurement of gas exchange in intensive care: Laboratory and clinical validation of a new device. Crit Care Med 1989; 17: 1041-1047.
7. Friedli B, Langford KBS, Mustard WT, Keith JD. Ventricular septal defect with increased pulmonary vascular resistance. Late results of surgical closure. Am J Cardiol 1974; 33: 403-409.
8. Bush A, Bust CM, Haworth SG, et al. Correlations of lung morphology, pulmonary vascular disease, and outcome in children with congenital heart disease. Br Heart J 1988; 59: 480-485.
9. Morita K, Ihnken K, Buckberg GD, Sherman MP, Ignarro LJ. Pulmonary vasoconstriction due to impaired nitric oxide production after cardiopulmonary by-pass. Ann Thorac Surg 1996; 61: 1775-1780.
10. Berner M, Beghetti M, Spahr-Schofer I, Oberhansli I, Friedli B. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease. Am J Cardiol 1996; 77: 532-535.
11. Roberts JRJD, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87: 447-453.
12. Winberg P, Lundell BPW, Gustafsson LE. Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congenital heart disease. Br Heart J 1994; 71: 282-286.
13. Beghetti M, Habre W, Friedli B, Berner M. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Br Heart J 1995; 73: 65-68.
14. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ. Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994; 108: 487-494.
15. Goldman AP, Delius RE, Deanfield JE, Macrae DJ. Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations. Ann Thorac Surg 1995; 60: 300-305.
16. Pepke-Zaba J, Higenbottam T, Dinh-Xuan A. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338: 1173-1174.
17. Roberts JRJD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 818-819.
18. Frostell C, Fratacci M-D, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide - a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038-2046.
19. Fratacci M-D, Frostell C, Chen T, Wain JC, Robinson DR, Zapol WM. Inhaled nitric oxide - a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 1991; 75: 990-999.
20. Curran RD, Mavroudis C, Backer LC, Sautel M, Zales VR, Wessel DL. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Ann Thorac Surg 1995; 60: 1765-1771.
21. Gerlach H, Rossaint R, Pappert D, Falke KJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993; 23: 499-502.
22. Girard C, Lehot J-J, Pannetier J-C, Filley S, Ffrench P, Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992; 77: 880-883.
23. Miller OI, Jame J, Elliot MJ. Intraoperative use of inhaled low-dose nitric oxide. J Thorac Vase Surg 1993; 105: 550-551.
24. Rich GF, Murphy GD, Roos MS, Johnson RS. Inhaled nitric oxide. Selective vasodilatation in cardiac surgical patients. Anesthesiology 1993; 78: 1028-1035.
25. Rich GF, Lowson SM, Johnson RA, Daugherty MO, Uncles DR. Inhaled nitric oxide selectively decreases pulmonary vascular resistance without impairing oxygenation during one-lung ventilation in patients undergoing cardiac surgery. Anesthesiology 1994; 80: 57-62.
26. Berner M, Beghetti M, Ricou B, Rouge JC, Pretre R, Friedli B. Relief of severe pulmonary hypertension after closure of a large ventricular septal defect using low dose inhaled nitric oxide. Intensive Care Med 1993; 19: 75-77.
27. Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W. Aerolized prostacyclin and Iloprost in severe pulmonary hypertension. Ann Intern Med 1996; 24: 820-824.
28. Okano Y, Yoshioka T, Shimouchi A, Satoh T, Takeyoshi K. Orally active prostacyclin analogue in primary pulmonary hypertension. Lancet 1997; 349: 1365-1365.
29. Adatia I, Wessel DL. Therapeutic use of inhaled nitric oxide. Curr Opin Pediatr 1994; 6: 583-590.
30. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide. Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 110-142.
31. Miller OI, Celermajer DS, Deanfield JE, et al. Guidelines for the safe administration of inhaled nitric oxide. Arch Dis Child 1994; 70: F47-49.
32. Foubert L, Fleming B, Latimer R, et al. Safety guidelines for use of nitric oxide. Lancet 1992; 339: 1615-1616.
33. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynirite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624.
34. McElroy MC, Wiener-Kronish JP, Miyazaki H, et al. Nitric oxide attenuates lung endothelial injury caused by sublethal hyperoxia in rats. Am J Physiol 1997; 272: L631-638.
35. Kinsella JP, Parker TA, Galan H, Sheridan BC, Halbower AC, Amban SH. Effects of nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 1997; 41: 457-463.
36. Buga GM, Griscavage JM, Rogers NE, Ignarro LJ. Negative feed-back regulation of endothelial cell function by nitric oxide. Circ Res 1993; 37: 808-812.